Telemus Capital’s Chemours CC Stock Holding History

Telemus Capital’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-100	Closed	-$5K	–	430
2017 Q4	$5K	Buy	+100	New	+$5.24K	﹤0.01%	552

Other funds holding CC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Telemus Capital's CC Position: Q1 2018 in Review

Telemus Capital sold out of Chemours (CC) in Q1 2018, closing a stake of 100 shares — an estimated $5K sold.

Telemus Capital first reported a position in CC in Q4 2017 and held it in 1 quarter. The position peaked at $5K in Q4 2017. 546 funds tracked by Wall St. Rank hold CC as of Q1 2018.

Telemus Capital reported no remaining Chemours position as of Q1 2018 after selling out during the quarter.
Telemus Capital sold 100 Chemours shares in Q1 2018, an estimated $5K.
Telemus Capital first reported a position in Chemours in Q4 2017 and held it in 1 quarter.
Telemus Capital's Chemours position peaked at $5K in Q4 2017.
546 funds tracked by Wall St. Rank held Chemours as of Q1 2018.

Based on Telemus Capital's 13F filing for Q1 2018, filed 27 Apr 2018.